Sara Bonstein

CIK 1604019 · Chief Financial Officer · last filed 2026-06-05

Sara Bonstein is a Chief Financial Officer who has filed 105 SEC Form 4 insider transactions across 6 companies since 2014. The most recent filing shows the insider sold $245.9K of INSM on Jun 5, 2026. Across all open-market trades the lifetime net is −$44.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.76M

Companies

6

Total Filings

105

Lifetime Open-Market Net

-$44.39M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INSM Chief Financial Officer 69,082 $97.85 $6.76M -$44.19M 33 2026-06-05
scPharmaceuticals Inc. (SCPH) Delisted Director $5.67 $0 7 2025-10-07
XLO Director $8.31 $0 4 2025-06-12
ONCOSEC MEDICAL Inc (ONCS) Delisted CFO/COO 41,389 $0.28 $11.5K -$5.0K 8 2020-01-21
Ayala Pharmaceuticals, Inc. (ADXSW) Delisted Chief Financial Officer 226,670 -$110.7K 21 2018-04-03
Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted Chief Financial Officer 81,577 -$83.9K 32 2016-10-04

Recent Filings

105 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 INSM Sell (S) −2,404 -$245.9K EDGAR
2026-05-15 INSM Sell (S) −8,272 -$961.0K EDGAR
2026-02-04 INSM Sell (S) −748 -$116.9K EDGAR
2026-01-08 INSM Sell (S) −4,642 -$808.7K EDGAR
2026-01-06 INSM Grant (A) +11,643 $0 EDGAR
2025-10-07 scPharmaceuticals Inc. (SCPH) Delisted Disp (D) $0 EDGAR
2025-07-23 INSM Mixed −10,512 -$4.53M EDGAR
2025-07-09 INSM Mixed −9,876 -$4.32M EDGAR
2025-06-25 INSM Mixed −9,876 -$4.96M EDGAR
2025-06-12 INSM Mixed −9,876 -$4.29M EDGAR
Showing 110 of 105
Page 1 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.